Age: 70.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthma, Influenza like illness, Laboratory test, Mouth swelling, Myasthenia gravis
Clinical narrative: patient developed asthma symptoms/she couldn't breath; patient developed flu like symptoms; swelling in her mouth; swelling in the back of her throat; swelling in her tongue; trouble with speech; she had a hard time swallowing; This spontaneous case was reported by a patient and describes the occurrence of ASTHMA (patient developed asthma symptoms/she couldn't breath), INFLUENZA LIKE ILLNESS (patient developed flu like symptoms), MOUTH SWELLING (swelling in her mouth), PHARYNGEAL SWELLING (swelling in the back of her throat) and SWOLLEN TONGUE (swelling in her tongue) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient had never been diagnosed with/ tested positive for COVID-19. It was reported that the patient had no acute, chronic or long standing health conditions at the time of vaccination.Patient did not received any other vaccine within 1 month prior to Moderna COVID-19 vaccine. Patient experienced something very mild with seasonal allergies in the past. Patient seek medical care to general practitioner. She has no history of Myocarditis/pericarditis but her father died because of a stroke and he had atherosclerosis.  Family history included Cardiac disorder (Atorvastatin used for family history of cardiac disease) since an unknown date. Concurrent medical conditions included Penicillin allergy and Seasonal allergy. Concomitant products included ATORVASTATIN for Family history of cardiovascular disorder, METFORMIN for Family history of diabetes, METOPROLOL for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced ASTHMA (patient developed asthma symptoms/she couldn't breath), INFLUENZA LIKE ILLNESS (patient developed flu like symptoms), MOUTH SWELLING (swelling in her mouth), PHARYNGEAL SWELLING (swelling in the back of her throat), SWOLLEN TONGUE (swelling in her tongue), SPEECH DISORDER (trouble with speech) and DYSPHAGIA (she had a hard time swallowing). The patient was treated with CHLORTHALIDONE for Swelling, at a dose of 25 milligram once a day; AMLODIPINE BESYLATE for Swelling, at a dose of 5 milligram once a day and MONTELUKAST SODIUM for Asthma, at a dose of 10 milligram once a day. At the time of the report, ASTHMA (patient developed asthma symptoms/she couldn't breath) and DYSPHAGIA (she had a hard time swallowing) was resolving and INFLUENZA LIKE ILLNESS (patient developed flu like symptoms), MOUTH SWELLING (swelling in her mouth), PHARYNGEAL SWELLING (swelling in the back of her throat), SWOLLEN TONGUE (swelling in her tongue) and SPEECH DISORDER (trouble with speech) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication Metformin she was using because of family history. Patient visited to her general practitioner and treatment given to have breathing under control were anti-inflammatory medications to reduce swelling and asthma medication were given. Breathing improved 1 or 2 days later, and difficulty swallowing improved in 2 or 3 days, but it wasn't completely resolved. .   This case was linked to MOD-2022-637082, MOD-2022-637080.